• No results found

Fc γ receptors and the complement system in T cell activation Jong, J.M.H. de

N/A
N/A
Protected

Academic year: 2021

Share "Fc γ receptors and the complement system in T cell activation Jong, J.M.H. de"

Copied!
9
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Fc γ receptors and the complement system in T cell activation

Jong, J.M.H. de

Citation

Jong, J. M. H. de. (2007, December 13). Fc γ receptors and the complement system in T cell activation. Retrieved from https://hdl.handle.net/1887/12491

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden

Downloaded from: https://hdl.handle.net/1887/12491

Note: To cite this publication please use the final published version (if applicable).

(2)

FcγReceptors and the complement

system in T cell activation.

Judith M.H. de Jong

(3)
(4)

FcγReceptors and the complement system in

T cell activation.

PROEFSCHRIFT

ter verkrijging van

de graad van Doctor aan de Universiteit Leiden,

op gezag van Rector Magnificus prof. mr. P.F. van der Heijden, volgens besluit van het College voor Promoties

te verdedigen op donderdag 13 december 2007 klokke 13.45 uur

door

Judith Maria Hendrika de Jong geboren te Breda in 1977

(5)

Promotiecommissie:

Promotor: Prof. Dr. T.W.J. Huizinga Co-promotoren: Dr. R.E.M. Toes

Dr. J.S. Verbeek

Referent: Dr. T.R.D.J. Radstake Universitair Medisch Centrum Nijmegen Overige leden: Prof. Dr. M.R. Daha

Prof. Dr. P.S. Hiemstra

The research presented in this thesis was performed at the department of Rheumatology of the Leiden University Medical Center, The Netherlands, and was supported by a grant of the Dutch Organization for Scientific Research.

Financial support for the publication of this thesis was provided by the J.E. Jurriaanse Stichting, the Dutch Arthritis Foundation and Sticares InterACT BV.

Used by permission: Chapter 3 - ©2007 The American Association of Immunologists, Inc.

ISBN: 90-9022169-4

Cover: Dennis Blaak, Vormtaal Druk: Ponsen & Looijen

(6)

Voor mama

(7)
(8)

Contents

Chapter 1 General Introduction 9

Chapter 2 Dendritic cells, but not macrophages or B cells, activate 27 MHC class II-restricted CD4+ T cells upon immune-

complex uptake in vivo.

Immunology 2006; 119:499-506

Chapter 3 A novel role of complement factor C1q in augmenting 37 the presentation of antigen captured in immune complexes

to CD8+ T lymphocytes.

J. Immunol. 2007; 178:7581-7586

Chapter 4 Murine Fc Receptors for IgG are redundant in facilitating 45 presentation of immune complex derived antigen to CD8+

T cells in vivo.

Mol. Immunol. 2006; 43:2045-2050

Chapter 5 Single Nucleotide Polymorphisms (SNPs) in the C5 gene 53 associate with susceptibility to RA.

Chapter 6 Summary and discussion 69

Nederlandse samenvatting 77

Nawoord 86

Curriculum Vitae 88

(9)

Referenties

GERELATEERDE DOCUMENTEN

Our results revealed that DC, but not macrophages or B cells are able to acti- vate CD4 + T cells efficiently following FccR-facilitated antigen capture, despite the fact

MHC class I Ag presentation of OVA-derived peptides in vivo was analyzed by using CD8 ⫹ T cells derived from OT-I/CD45.1 transgenic mice, which have a transgenic TCR specific for

To study the contribution of the different Fc ␥R and complement receptors in IC-facilitated Ag-presentation, we analyzed the ovalbumin(OVA)- specific CD8 + T cell proliferation in

That the complement network plays a role in human RA was for the first time detected, indirectly, by the colocalization of C3 fragments with immune complexes in joint tissue 12 ,

To study the contribution of the different FcγR and complement receptors in presentation of subcutaneously administrated IC, we analyzed in chapter 4 the ovalbumin(OVA)-specific CD8

In hoofdstuk 3 hebben we gekeken naar de rol van FcγReceptoren en het complement systeem in de presentatie van IC aan CD8 + T-cellen door IC in de bloedbaan te spuiten van

Danita Schuurhuis, Andreea Ioan en Nadine van Montfoort; bedankt voor jullie samenwerking, steun en al jullie ideeën tijdens de “IC-meetings”!. Ellen van der Voort, bedankt voor al

Het feit dat C5aR -/- muizen geen artritis ontwikkelen na injectie met anticollageen antilichamen wijst niet op een verlaagde antilichaam productie en de daaropvolgende